API Solubility and Bioavailability

white-paperLaboratoria Smeets S.A
December 5th 2012

Labo Smeets specialises in API solubility and bioavailability using a patented process based upon twin screw extrusion technology.

In the full article Labo Smeets managing director Jef Verplaetse explains how twin screw extruders can improve the bioavailability of medicines that are not easily soluble in water. Labo Smeets has collaborated with Ghent University and has developed a granulation technique for converting poorly soluble drugs into highly soluble granules.

If you are interested in our technology for API solubility and bioavailability (e.g. for some antibiotics), please contact us directly.

To read the full article please click on the link below:
API Solubility and Bioavailability